Sterling Biotech bank fraud case,ED attaches property worth 4700 crores Medical Dialogues Bureau8 Dec 2018 10:20 AM ISTNew Delhi: The Enforcement Directorate (ED) on Friday, after a seven-month-long probe, attached several movable and immovable properties worth more...
NCLT dismisses HDFC insolvency plea against RHC Holding Farhat Nasim8 Dec 2018 10:15 AM ISTNEW DELHI: National Company Law Tribunal (NCLT) on Thursday dismissed HDFC Ltd's insolvency plea against RHC Holding, observing that the non-banking...
Bayer reduces combined sales estimate for its experimental drugs Medical Dialogues Bureau8 Dec 2018 9:20 AM ISTFRANKFURT: Germany's Bayer, which acquired seed company, Monsanto, this year, reduced its combined sales estimate for its most promising experimental...
AstraZeneca enters distribution agreement with Abbott for diabetes drug Medical Dialogues Bureau8 Dec 2018 9:00 AM ISTNew Delhi: Drug firm AstraZenecaPharma India Friday said it has entered into a distribution agreement with Abbott Healthcare for distribution of...
Alembic Pharma plans to get upto Rs 500 crore through NCDs Farhat Nasim7 Dec 2018 9:50 AM ISTNew Delhi: Drug firm Alembic Pharma on Thursday said it plans to raise up to Rs 500 crore through issue of non-convertible debentures (NCDs) on...
Novartis to launch epinephrine-rival to EpiPens Farhat Nasim7 Dec 2018 9:30 AM ISTNew Delhi: Novartis AG said its U.S. unit Sandoz Inc will launch Adamis Pharmaceuticals Corp's emergency allergy shots next year in the United States,...
Alembic Pharma gets USFDA nod for Candesartan Cilexetil tablets Medical Dialogues Bureau7 Dec 2018 9:15 AM ISTNew Delhi: Drug firm Alembic Pharma on Wednesday said it has received approval from the US health regulator for Candesartan Cilexetil tablets, used...
AbbVie stops enrollment for a late-stage trial of Rova-T Medical Dialogues Bureau7 Dec 2018 9:00 AM ISTNew Delhi: AbbVie Inc said on Wednesday it had halted enrollment for a late-stage trial of Rova-T as a second-line therapy for advanced small-cell...
Apollo Hospitals pharmacy divest front-end biz,credit neutral Medical Dialogues Bureau6 Dec 2018 9:45 AM ISTNew Delhi: Apollo Hospitals Enterprise' decision to divest its front-end pharmacy business to Apollo Pharmacy Ltd (APL) for cash consideration of Rs...
Roche's Tecentriq wins priority review in U.S for treatment of lung cancer Medical Dialogues Bureau6 Dec 2018 9:30 AM ISTZURICH: Roche's Tecentriq immunotherapy with chemotherapy won priority review in the United States for the initial treatment of extensive-stage small...
Sanofi plans to reduce 670 jobs,efficiency to be affected Medical Dialogues Bureau6 Dec 2018 9:30 AM ISTPARIS: French drugmaker Sanofi told unions on Wednesday it was planning to cut 670 jobs in France, a union representative told Reuters.The plan, which...
Takeda shareholders nod to $59 billion Shire acquisition Medical Dialogues Bureau6 Dec 2018 9:00 AM ISTOSAKA: Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeovers of London-listed Shire, creating a global powerhouse with a...
